PCRX FY 2009 Earnings — Pacira BioSciences, Inc. Revenue & Financial Results | Market Cap Arena

PCRXPacira BioSciences, Inc.

$976M

FY 2009 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$15M+7.8% YoY

Gross Profit

$3M18.0% margin

Operating Income

-$29M-190.2% margin

Net Income

-$32M-211.3% margin

EPS (Diluted)

$-55.32

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$26M

Stock-Based Comp.

$524,000

Balance Sheet

Total Assets

$44M

Total Liabilities

$67M

Stockholders' Equity

-$23M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$14M	+7.8%
Gross Profit	$3M	-$4M	+176.5%
Operating Income	-$29M	-$45M	+37.1%
Net Income	-$32M	-$42M	+24.3%